Molecular imaging plays a pivotal role in disease diagnosis and treatment through visualization of physiological, biochemical and biomolecular processes in living systems at cellular and subcellular levels. It enables earlier and more accurate diagnosis of diseases like cancer, helping physicians to create more effective treatment plans. Molecular imaging enables precise visualization of how organs and tissues function and allows easy detection of disease in early stages. The global Molecular Imaging Market is estimated to be valued at US$ 4786.94 Mn in 2024 and is expected to exhibit a CAGR of 15.% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
One of the key trends driving growth in the molecular imaging market is the rising adoption of hybrid imaging systems. Hybrid imaging systems such as PET-CT and PET-MRI combine the attributes of two different imaging modalities to provide complementary anatomical and functional information from a single scanning session. This enhances medical imaging capabilities and helps deliver more precise diagnosis. Hybrid imaging has emerged as an effective approach for non-invasive disease characterization. As hybrid imaging integrates advanced technologies, it enables more accurate clinical visualization and management of diseases at molecular level. This significantly contributes to early detection and efficacy of treatments. Increasing utilization of hybrid imaging will spur demand in the molecular imaging market during the forecast period.
Segment Analysis
The global molecular imaging market is dominated by positron emission tomography (PET) segment which accounts for over 45% market share in 2024. PET utilizes radioactive isotopes for imaging biological processes at the molecular level. It provides precise information regarding metabolic processes occurring within the body which helps in early detection of cancer and other diseases. This ability to precisely detect biological changes at the molecular level makes PET widely used for oncology and neurology applications.
Key Takeaways
The global Molecular Imaging Market Growth is expected to witness high growth over the forecast period of 2023 to 2030 supported by rising geriatric population, technological advancements and increasing applications of molecular imaging.
Regional analysis: North America is expected to dominate the global molecular imaging market through 2030 owing to rising healthcare expenditure, advanced healthcare infrastructure and higher adoption of molecular imaging technologies.Asia Pacific is anticipated to grow at the fastest pace supported by growing medical tourism, improving regulatory framework as well as ongoing infrastructure development initiatives in developing countries like India and China.
Key players operating in the molecular imaging market are Seattle's VillageReach, Flirtey, Ehang, ZipLine, TU Delft, Google Drones, Project Wing, Healthcare Integrated Rescue Operations (HiRO), Vayu Drones. These players are focusing on new product launches, partnerships and regional expansions to strengthen their market presence.
For more insights, read- https://www.newsanalyticspro.com/molecular-imaging-market-trends-size-and-share-analysis-2/
Comments
0 comment